Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cobas® liat CT/NG/MG nucleic acid test

K-Number: K240197 · 2025-01-16

Decision Date2025-01-16
Product CodeQEP
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

cobas® liat CT/NG/MG nucleic acid test is a medical device manufactured by Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2025-01-16 under approval number K240197. The device is classified under product code QEP. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cobas® liat CT/NG/MG nucleic acid test?

cobas® liat CT/NG/MG nucleic acid test is a medical device that received FDA 510(k) clearance on 2025-01-16. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K240197.

When was cobas® liat CT/NG/MG nucleic acid test approved by the FDA?

cobas® liat CT/NG/MG nucleic acid test received FDA 510(k) clearance on 2025-01-16, under approval number K240197.

What company makes cobas® liat CT/NG/MG nucleic acid test?

cobas® liat CT/NG/MG nucleic acid test is manufactured by Roche Molecular Systems, Inc..

What is the FDA product code for cobas® liat CT/NG/MG nucleic acid test?

The FDA product code for cobas® liat CT/NG/MG nucleic acid test is QEP.

Other Devices by Roche Molecular Systems, Inc.

View all 47 devices →

Related Devices (Code: QEP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.